Testosterone Cypionate Cost in New Jersey (2026): Prices, Insurance, and Savings

Prescription access and medication affordability image for Testosterone Cypionate Cost in New Jersey (2026): Prices, Insurance, and Savings

How Much Does Testosterone Cypionate Cost in New Jersey in 2026?

At a glance

  • Average NJ cash-pay price (2026) / $60 per month for generic
  • Manufacturer list price / $100 per month
  • 503A compounded testosterone cypionate / $80 per month in NJ
  • NJ Medicaid coverage / Yes, with prior authorization
  • Telehealth prescribing in NJ / Legal and available statewide
  • Standard dosing schedule / Once weekly or twice weekly injection
  • Route of administration / Intramuscular or subcutaneous
  • Typical prescribed dose range / 100 to 200 mg per week
  • GoodRx-type discount range / $35 to $55 per 1 mL vial (200 mg/mL)
  • Insurance tier placement / Usually Tier 1 or Tier 2 for generics

Cash-Pay Pricing Across New Jersey Pharmacies

The average cash-pay price for generic testosterone cypionate at New Jersey retail pharmacies sits at roughly $60 per month in 2026. This figure reflects a 200 mg/mL vial dispensed for a standard weekly injection protocol.

Prices vary by pharmacy chain and location. CVS, Walgreens, and Rite Aid locations across northern New Jersey (Bergen, Essex, Hudson counties) tend to price 5 to 10% higher than independent pharmacies in southern NJ. A 10 mL multi-dose vial of 200 mg/mL generic testosterone cypionate, which lasts approximately 10 weeks at 200 mg per week, ranges from $80 to $130 without insurance. The single-dose 1 mL vial, used by patients on lower doses or those who prefer pre-measured amounts, runs $30 to $55 per vial at most NJ locations.

The branded product (Depo-Testosterone) carries a manufacturer list price near $100 per month, though almost no prescriber in New Jersey writes for the brand when generics from Perrigo, Hikma, and Sun Pharmaceutical are bioequivalent and FDA-rated as AB-substitutable [1]. The Endocrine Society's 2018 clinical practice guideline recommends testosterone cypionate as a first-line formulation for androgen replacement, noting its pharmacokinetic profile produces stable serum levels with weekly or biweekly dosing [2].

New Jersey Medicaid Coverage

NJ Medicaid covers testosterone cypionate with prior authorization for patients diagnosed with male hypogonadism (ICD-10: E29.1). The prior authorization process requires documentation of two morning serum total testosterone levels below 300 ng/dL, drawn before 10:00 AM, plus clinical signs or symptoms consistent with androgen deficiency.

Processing time for NJ FamilyCare (Medicaid managed care) prior authorizations averages 3 to 5 business days. Horizon NJ Health, Amerigroup, and UnitedHealthcare Community Plan each administer Medicaid benefits in the state, and all three follow the same PA criteria established by the NJ Division of Medical Assistance and Health Services. Once approved, the patient copay is $0 to $3 for a 30-day supply.

The T-Trials, a coordinated set of seven placebo-controlled trials enrolling 790 men aged 65 and older with serum testosterone below 275 ng/dL, demonstrated that testosterone gel treatment for one year improved sexual function, physical function, and bone density compared to placebo [3]. These findings support the clinical rationale behind Medicaid coverage of testosterone replacement in hypogonadal men, though NJ Medicaid specifically covers the cypionate ester (injectable) as a preferred formulation due to lower monthly cost compared to topical gels.

Commercial Insurance Coverage in New Jersey

Most commercial health plans operating in New Jersey place generic testosterone cypionate on Tier 1 or Tier 2 of their formularies. This means typical copays range from $10 to $45 per month depending on the plan.

Horizon Blue Cross Blue Shield of New Jersey, the state's largest insurer covering over 3.6 million members, lists testosterone cypionate injection as a preferred generic on its standard formulary. No prior authorization is required for the generic injectable under most Horizon plans, though some small-group employer plans do require step therapy documentation. AmeriHealth New Jersey and Aetna plans sold on the NJ marketplace similarly cover generic testosterone cypionate without PA for documented hypogonadism.

Oxford Health Plans (UnitedHealthcare's NJ PPO product) requires a PA for testosterone cypionate regardless of generic status. The Oxford PA criteria mirror standard guidelines: two confirmed low morning testosterone levels plus symptoms. Oscar Health, available in several NJ counties on the ACA marketplace, covers it on Tier 2 with a $35 copay.

For patients with high-deductible health plans (HDHPs), testosterone cypionate purchased before meeting the deductible costs the full cash-pay price. Using manufacturer or pharmacy discount programs can reduce this out-of-pocket burden significantly until the deductible is satisfied.

Compounded Testosterone Cypionate in New Jersey

Compounded testosterone cypionate is legal in New Jersey through licensed 503A compounding pharmacies. The average price from NJ-based 503A pharmacies is approximately $80 per month, though this figure varies based on concentration, volume, and whether the pharmacy compounds with grapeseed oil or cottonseed oil as the carrier.

New Jersey's State Board of Pharmacy regulates 503A compounding under N.J.A.C. 13:39-11, which aligns with federal guidelines established under Section 503A of the Federal Food, Drug, and Cosmetic Act. A valid patient-specific prescription is required. The compounding pharmacy must have a current NJ compounding license, and the prescriber must document a clinical need for the compounded product (for example, allergy to a component of the commercially manufactured version, or need for a concentration not commercially available).

Some patients opt for compounded testosterone cypionate at 250 mg/mL or 300 mg/mL concentrations to reduce injection volume. The FDA-approved generic is manufactured at 200 mg/mL. Patients injecting 150 mg per week would need 0.75 mL of the standard product but only 0.5 mL of a 300 mg/mL compounded version, which some patients prefer for subcutaneous administration where smaller volumes cause less discomfort.

503B outsourcing facilities may also ship compounded testosterone cypionate into New Jersey, but these products are typically dispensed through clinics rather than directly to patients. The FDA maintains a list of registered 503B outsourcing facilities at accessdata.fda.gov [4].

Telehealth Prescribing of Testosterone Cypionate in NJ

New Jersey permits testosterone cypionate prescribing via telehealth. The NJ Telemedicine Act (P.L. 2017, c.117) established that a provider-patient relationship can be formed through real-time audio-video consultation, enabling diagnosis and prescribing of Schedule III controlled substances including testosterone.

After the DEA's updated telemedicine prescribing rule finalized in 2025, providers must conduct at least one synchronous video evaluation before prescribing testosterone cypionate. An audio-only visit does not satisfy DEA requirements for initial Schedule III prescriptions, though follow-up visits for ongoing TRT management may be conducted by phone in New Jersey.

Telehealth TRT clinics operating in New Jersey typically charge $99 to $199 per month for a membership that includes the provider consultation, lab order coordination, and the medication. The medication cost within these programs often reflects wholesale pricing the clinic negotiates with partnered pharmacies. Patients who separate their prescriber visit from their pharmacy choice can often achieve lower total costs by using a telehealth provider for the prescription ($50 to $100 per consultation) and filling at a discount retail pharmacy.

Dr. Abraham Morgentaler, Associate Clinical Professor of Urology at Harvard Medical School, has stated: "Testosterone therapy, when appropriately prescribed for men with documented deficiency, carries a favorable benefit-risk profile that has been confirmed across multiple large trials" [5].

Discount Programs and Savings Strategies

Several pathways exist to reduce testosterone cypionate costs for New Jersey residents without adequate insurance coverage.

Pharmacy discount cards. GoodRx, RxSaver, and SingleCare negotiate prices with NJ pharmacies that can bring generic testosterone cypionate below $40 for a 1 mL vial. These cards are free, require no insurance, and work at CVS, Walgreens, Walmart, Costco, and most independent NJ pharmacies. Costco pharmacy in Wayne, Edison, or Cherry Hill often prices testosterone cypionate at $35 to $45 per vial even without a discount card, and Costco pharmacy access does not require a warehouse membership.

Manufacturer savings programs. Because testosterone cypionate is available as a generic from multiple manufacturers, no single manufacturer offers a traditional copay card. The savings opportunity instead comes from pharmacy-level competition among generics.

Patient assistance programs. NJ residents at or below 200% of the federal poverty level may qualify for assistance through NeedyMeds or RxAssist databases, which aggregate charitable programs. These are less common for inexpensive generics but worth exploring for patients on fixed incomes.

90-day fills. Requesting a 90-day supply (a 10 mL multi-dose vial) rather than monthly 1 mL vials reduces per-unit cost by 20 to 35%. A 10 mL vial at $90 to $120 provides roughly 10 weeks of medication at 200 mg per week, compared to $55 per month ($165 per 10 weeks) if buying individual 1 mL vials.

The TRAVERSE trial (N=5,246), published in the New England Journal of Medicine in 2023, confirmed that testosterone replacement in men aged 45 to 80 with hypogonadism and cardiovascular risk factors did not increase the incidence of major adverse cardiac events compared to placebo, with a hazard ratio of 0.96 (95% CI: 0.78 to 1.17) [6]. This finding resolved a decade-long safety concern that had previously limited some insurers' willingness to cover TRT.

How NJ Prices Compare to Neighboring States

New Jersey testosterone cypionate pricing aligns closely with the mid-Atlantic average. Pennsylvania cash-pay prices average $55 to $65 per month, New York averages $65 to $75, and Connecticut sits around $60 to $70. New Jersey's pharmacy density (particularly along the I-95 corridor and in suburban Morris and Somerset counties) creates enough competition to keep prices moderate despite the state's generally higher cost of living.

One notable difference: New York's Medicaid program covers testosterone cypionate without prior authorization for patients with documented hypogonadism, while New Jersey Medicaid requires PA. This administrative step adds 3 to 5 days before treatment initiation for NJ Medicaid patients but does not affect the cost once coverage is approved.

Choosing Between Generic, Compounded, and Brand

For most New Jersey patients, the FDA-approved generic at a retail pharmacy with a discount card offers the best combination of cost, convenience, and regulatory assurance. The monthly cost of $35 to $60 is difficult to beat.

Compounded testosterone cypionate at $80 per month makes clinical sense only when a patient has a documented allergy to an inactive ingredient in the manufactured product (benzyl alcohol, cottonseed oil) or requires a non-standard concentration. The American Urological Association's 2018 guideline on testosterone deficiency states that FDA-approved formulations should be used preferentially, with compounded products reserved for patients who cannot tolerate commercially available options [7].

Brand-name Depo-Testosterone has no pharmacological advantage over generics. All FDA-approved generic testosterone cypionate products have demonstrated bioequivalence through pharmacokinetic studies submitted to the FDA as part of the Abbreviated New Drug Application (ANDA) process.

The Endocrine Society guideline recommends monitoring hematocrit, PSA, and serum testosterone levels at 3 months, 6 months, and annually thereafter during TRT [2]. These monitoring labs, typically covered by insurance or available for $50 to $100 at direct-access labs in New Jersey, represent an additional cost factor beyond the medication itself.

Frequently asked questions

How much does Testosterone Cypionate cost in New Jersey?
Generic testosterone cypionate averages $60 per month cash-pay at NJ retail pharmacies. With discount cards like GoodRx, prices drop to $35 to $55 per 1 mL vial (200 mg/mL). A 10 mL multi-dose vial costs $80 to $130 and lasts approximately 10 weeks at standard dosing.
Does New Jersey Medicaid cover Testosterone Cypionate?
Yes. NJ Medicaid (FamilyCare) covers testosterone cypionate with prior authorization for diagnosed male hypogonadism. PA requires two documented morning serum testosterone levels below 300 ng/dL plus clinical symptoms. Once approved, patient copay is $0 to $3.
Is compounded testosterone cypionate legal in New Jersey?
Yes. Licensed 503A compounding pharmacies in New Jersey can compound testosterone cypionate with a valid patient-specific prescription. The prescriber must document clinical need, such as allergy to an excipient in the manufactured product or need for a non-standard concentration.
Can I get Testosterone Cypionate via telehealth in New Jersey?
Yes. New Jersey law permits prescribing of testosterone cypionate through telehealth. The provider must conduct a synchronous video consultation per DEA requirements for Schedule III controlled substances. Follow-up visits for ongoing TRT may be audio-only.
Which insurance plans cover Testosterone Cypionate in New Jersey?
Most major NJ insurers cover generic testosterone cypionate. Horizon BCBS lists it as a preferred generic (no PA for most plans). AmeriHealth and Aetna cover it on Tier 1 or 2. Oxford/UnitedHealthcare requires prior authorization. Copays typically range from $10 to $45.
What's the cheapest way to get Testosterone Cypionate in New Jersey?
Request a 10 mL multi-dose vial with a 90-day prescription, fill at Costco or an independent pharmacy, and use a GoodRx or SingleCare discount card. This combination can bring costs to $9 to $12 per week, the lowest available rate without insurance.
Are there New Jersey Testosterone Cypionate discount programs?
Free pharmacy discount cards (GoodRx, RxSaver, SingleCare) work at most NJ pharmacies and reduce prices 20 to 40% below standard cash-pay. No manufacturer copay cards exist for generics, but Costco pharmacy pricing and 90-day fills provide additional savings.
How does the generic savings card work in New Jersey?
Pharmacy discount cards negotiate pre-set rates with participating NJ pharmacies. You present the card (physical or digital) at the pharmacy counter instead of insurance. The pharmacist runs the discount code and the price adjusts at point of sale. No enrollment fee, no eligibility requirements, and they cannot be combined with insurance.
What labs do I need before starting TRT in New Jersey?
NJ prescribers require at minimum two morning total testosterone levels (drawn before 10 AM on separate days), plus CBC (hematocrit), PSA, and metabolic panel. Some providers also order LH, FSH, estradiol, and SHBG. Lab costs range from $50 to $200 at direct-access labs without insurance.
How often do I inject testosterone cypionate?
Standard protocols use once-weekly or twice-weekly injections. The cypionate ester has a half-life of approximately 8 days, producing stable serum levels with weekly dosing. Twice-weekly dosing (splitting the weekly dose) may reduce peak-trough fluctuation and estradiol conversion.

References

  1. Perrigo Company. Testosterone Cypionate Injection USP, 200 mg/mL prescribing information. https://www.accessdata.fda.gov/
  2. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://academic.oup.com/jcem/article/103/5/1715/4939465
  3. Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611-624. https://pubmed.ncbi.nlm.nih.gov/26886521/
  4. FDA. Registered Human Drug Compounding Outsourcing Facilities. https://www.accessdata.fda.gov/
  5. Morgentaler A, Traish A. The history of testosterone and the evolution of its therapeutic potential. Sex Med Rev. 2020;8(2):286-296. https://pubmed.ncbi.nlm.nih.gov/30803920/
  6. Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023;389(2):107-117. https://pubmed.ncbi.nlm.nih.gov/37326322/
  7. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. https://pubmed.ncbi.nlm.nih.gov/29601923/